We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IFF:NYSEInternational Flavors & Fragrances, Inc. Analysis

Data as of 2026-03-11 - not real-time

$72.85

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

International Flavors & Fragrances (IFF) is trading at $72.85, well below its 20‑day SMA of 79.38 and 50‑day SMA of 74.05, indicating short‑term weakness, while still sitting above the 200‑day SMA of 69.73, which supports a longer‑term bullish bias. The RSI of 37 suggests the stock is approaching oversold territory, but the bearish MACD histogram (‑1.38) and decreasing volume raise concerns of further downside toward the nearest support at $71.21. On the fundamentals side, IFF posted a negative trailing EPS of ‑$1.41 and a profit margin of ‑3.3%, yet forward earnings are projected at $4.80 with a forward P/E of 15.16, and free cash flow remains healthy at $3.09 B. The balance sheet shows a high debt load ($6.65 B) versus cash ($0.59 B) and a debt‑to‑equity ratio of 46.9%, while the dividend payout ratio exceeds 160%, flagging sustainability issues despite a 2.2% yield. Analyst sentiment is positive, highlighted by an Oppenheimer upgrade and a consensus “Buy” with a median target of $90, implying ~24% upside, and the market sentiment index reads “Extreme Greed” at 76.9.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price hovering near technical support at $71.21
  • Bearish MACD and decreasing volume
  • Negative recent earnings and high payout ratio

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward earnings estimate of $4.80 and forward P/E ~15
  • Analyst upgrade and consensus “Buy” with target median $90
  • Undervalued relative to DCF fair value of $144

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong free cash flow generation
  • Potential for margin improvement in specialty chemicals
  • High debt load and dividend sustainability concerns

Key Metrics & Analysis

Financial Health

Revenue Growth-6.60%
Profit Margin-3.32%
P/E Ratio15.2
ROE-2.56%
ROA2.06%
Debt/Equity46.88
P/B Ratio1.3
Op. Cash Flow$850.0M
Free Cash Flow$3.1B

Technical Analysis

TrendBullish
RSI37.2
Support$71.21
Resistance$84.45
MA 20$79.38
MA 50$74.05
MA 200$69.73
MACDBearish
VolumeDecreasing
Fear & Greed Index76.91

Valuation

Fair Value$144.14
Target Price$90.71
Upside/Downside24.51%
GradeUndervalued
TypeBlend
Dividend Yield2.20%

Risk Assessment

Beta0.70
Volatility34.31%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.